Webinars
Selectivity Profiling: Unbiased Analysis of Compound Selectivity in Drug Discovery
Join us for an in-depth webinar exploring how CETSA® Selectivity Profiling empowers smarter decision-making in drug discovery. Drew Nager will share how Pfizer Oncology leverages Pelago Bioscience’s C...
Novel Applications of the Cellular Thermal Shift Assay (CETSA) Provide New Insights for Drug Discovery
Join AbbVie scientists Shitalben Patel and Jami R. Erickson as they showcase their innovative advancements, transforming CETSA® into a high-throughput flow-based platform and introducing new whole blo...
How CETSA® Enhances Translational Studies – A Sitryx Case Study
Bridging the Gap Between In Vitro and In Vivo Drug Discovery Translating early-stage drug discovery into clinical success is one of the biggest challenges in drug development. Ensuring that targ...
Uncovering Novel Modulators of PLCγ2 in Alzheimer’s Research with CETSA®
We are pleased to present our on-demand webinar, “How CETSA® has been applied in Lead Generation delivering novel modulators of PLCγ2,” featuring Fiona Jeganathan, Head of Pharmacology and...
Fungal Genomes in Drug Discovery: Application of CETSA® to Study the Mechanism of Action of Brefeldin A
In this webinar, you will find the details of the project where CETSA® Explore was leveraged to study the biological mechanism of the fungal polyketide lactone Brefeldin A (BFA) in human THP-1 cells. ...
Label-free validation of protein degraders using CETSA®
In this webinar, you will learn how Pelago Bioscience can support the early stages of hit identification and validation in a high throughput manner with CETSA® Navigate HT and how CETSA® Explore provi...
High Throughput CETSA® in Lead Generation
In this webinar, you will find a presentation by Dr. Joseph Shaw, Associate Principal Scientist, Discovery Sciences, R&D, AstraZeneca. To deliver the next generation of medicines, drug discovery m...